FOIA Request Filed As Avastin Safety Hearing Nears

Law360, New York (April 27, 2011, 7:29 PM EDT) -- A Baker Hostetler partner was among those filing a Freedom of Information Act request Wednesday in an attempt to stop the U.S. Food and Drug Administration from pulling its approval of Genentech Inc.'s Avastin drug for use in breast cancer patients.

The FOIA request asked for communications between the FDA and various outside parties, discussions related to the costs of Avastin in the FDA review process, and potential conflicts of interest by those who made the Avastin decision. It also asked for documents related to risk...
To view the full article, register now.